Home
Natco Pharma Ltd EPS

Natco Pharma Ltd
NSE: NATCOPHARM
EPS
Key Highlights
- The Earning per Share of Natco Pharma Ltd is ₹ 104.13 as of 21 Feb 25 .
- The earning per share of Natco Pharma Ltd changed from ₹ 23.26 to ₹ 7.43 over 7 quarters. This represents a CAGR of -47.91% .
Historical Earning per Share of Natco Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Natco Pharma Ltd
Company Fundamentals for Natco Pharma Ltd
Market Cap
14,288 Cr
EPS
104.1
P/E Ratio (TTM)
7.7
P/B Ratio (TTM)
2.0
Day’s High
815.45
Day’s Low
777.3
DTE
0.0
ROE
27.2
52 Week High
1638.35
52 Week Low
777.3
ROCE
32.3
Market Price of Natco Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 797.75 |
20 Feb 2025 | 793 |
19 Feb 2025 | 812.55 |
18 Feb 2025 | 834.6 |
17 Feb 2025 | 870.15 |
14 Feb 2025 | 883.7 |
13 Feb 2025 | 973.4 |
12 Feb 2025 | 1216.65 |
11 Feb 2025 | 1241.15 |
10 Feb 2025 | 1280.1 |
SWOT Analysis Of Natco Pharma Ltd
BlinkX Score for Natco Pharma Ltd
Asset Value vs Market Value of Natco Pharma Ltd
Market Value
₹ 14,288
Asset Value
Value addition
2.8 X
₹ 3,808
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Natco Pharma Ltd | 14288 | 104.13 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Natco Pharma Ltd | 14288 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Natco Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Natco Pharma Ltd
Historical Revenue of Natco Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Natco Pharma Ltd
Historical EBITDA of Natco Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Natco Pharma Ltd
Historical Net Profit of Natco Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Natco Pharma Ltd
Dividend Payout Over Time
Natco Pharma Ltd News Hub
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad
Read more
04 Sept 24
Natco Pharma fixes record date for second interim dividend
Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The
Read more
12 Aug 24
Board of Natco Pharma recommends dividend
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2
Read more
12 Aug 24
Natco Pharma schedules AGM
Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30
Read more
12 Aug 24